Medical News

RSS

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Currently, no definitive standard of care exists for adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL). Recent research suggests that AYAs treated with pediatric treatment protocols have better outcomes than those treated with adult treatment protocols.

5 Mar 2010

Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

IVAX Diagnostics, Inc., a fully integrated global in vitro diagnostics company, announced that Diamedix Corporation has signed a distribution agreement with Fumouze Diagnostics, a division of Sofibel S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be the exclusive third party distributor of Diamedix Corporation and Delta Biologicals S.r.l.’s suite of diagnostic tests in France. Diamedix is a U.S. subsidiary of IVAX Diagnostics and Delta Biologicals is IVAX Diagnostics’ subsidiary located in Italy. The initial term of the distribution agreement is three years.

5 Mar 2010

UnitedHealth Group statement: Expand access to quality care for all Americans

We sought to make clear our longstanding commitment to expanding access to quality care for all Americans, and also to discuss the many factors that are driving up the cost of care for millions of people across the United States. To achieve true and sustainable reform, it is essential to first bring costs under control.

5 Mar 2010

Chikungunya: Experimental vaccine successfully tested in monkeys

Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.

5 Mar 2010

Natural Solutions offers information about thyroid disease and thyroid medications

Is your thyroid making you fat? Around 27 million Americans have thyroid disease — and almost half don't know it. Thyroid disease arises when the hormone-producing gland at the base of your throat goes out of whack, triggering weight fluctuation, tiredness, and emotional ups and downs, among other symptoms.

5 Mar 2010

Neurocrine Biosciences to sell common stock shares

Neurocrine Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is the sole book-running manager for this offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

5 Mar 2010

Direct Supply to distribute GE QuietCare

GE Healthcare, a unit of GE announced today that it has entered into a distribution agreement for its flagship Home Health technology, GE QuietCare®, with Direct Supply Inc., a leading provider of eldercare equipment, eCommerce and service solutions to senior living facilities. Direct Supply will distribute and co-market GE QuietCare across the United States.

5 Mar 2010

Study finds Pfizer's pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients

Pfizer's Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawi, according to a study published Thursday in the New England Journal of Medicine, Reuters reports.

5 Mar 2010

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development.

5 Mar 2010

KAPIDEX to be marketed as DEXILANT in the U.S.

Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

5 Mar 2010

FDA's 5-year NCE exclusivity grant to VYVANSE: Court upholds decision

Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).

5 Mar 2010

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010.

5 Mar 2010

Chile has enough food, fuel for citizens, President says

Chilean President Michelle Bachelet said on Wednesday that the country has enough food and fuel to meet citizens' needs, Dow Jones Newswires reports. She said the government has adequate resources to enable business recovery and to help rebuild houses, and she wants the private sector to play a major role in the rebuilding effort. "Soon it will be the time to get back on our feet and entrepreneurs will be up to the challenge," she said, according to the news service.

5 Mar 2010

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

BioClinica™, Inc.,, a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.

From Clario 5 Mar 2010

Report finds public health funding is lagging as states cut back, federal programs remain flat

In a year when flagging state and local economies forced major cuts in public health spending, federal grants for disease prevention and emergency preparedness failed to fill the breach, according to a new report from The Robert Wood Johnson Foundation and the Trust for America's Health, which advocate for increased health spending.

5 Mar 2010

Risk of MS increases by many folds following infection with EBV: Study

Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV).

5 Mar 2010

Sebelius meets with insurance execs, challenges them to be transparent

Reuters: During a meeting today, Health and Human Services Secretary Kathleen Sebelius pressed the CEOs of some of the nation's largest health insurers about increases in insurance premiums. "The meeting added more uncertainty for an industry that has already become Democrats' top target in their bid to overhaul the nation's healthcare system, and shares of health insurers continued to fall in late-morning trading."

5 Mar 2010

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte’s lead regenerative medicine product using Xcellerex’s XDR single use bioreactor system in its FlexFactory®. Humacyte’s product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.

5 Mar 2010

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Positron Corporation a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale of its AttriusTM PET scanner to Ochsner Health System of Louisiana.

5 Mar 2010

Kyto Biopharma signs licensing agreement with RFSUNY, gains patent rights to Transcobalamin Receptor

Kyto Biopharma Inc., is pleased to announce that it has signed a licensing agreement with the Research Foundation of the State University of New York. The licensing agreement grants Kyto patent rights to the Transcobalamin (Vitamin B12) Receptor and to an additional broad group of other patents which are critical to Kyto’s research and development strategy for the treatment of cancer.

5 Mar 2010

Medical News

RMEI, PIM jointly sponsor virtual lecture to address the need for education on ALL in AYAs

Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

UnitedHealth Group statement: Expand access to quality care for all Americans

Chikungunya: Experimental vaccine successfully tested in monkeys

Natural Solutions offers information about thyroid disease and thyroid medications

Neurocrine Biosciences to sell common stock shares

Direct Supply to distribute GE QuietCare

Study finds Pfizer's pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients

Second AACR cancer research conference to be hosted in Dead Sea, Jordan

KAPIDEX to be marketed as DEXILANT in the U.S.

FDA's 5-year NCE exclusivity grant to VYVANSE: Court upholds decision

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Chile has enough food, fuel for citizens, President says

BioClinica announces partnerships with Health Sciences International and PRL Central Laboratory Services

Report finds public health funding is lagging as states cut back, federal programs remain flat

Risk of MS increases by many folds following infection with EBV: Study

Sebelius meets with insurance execs, challenges them to be transparent

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Kyto Biopharma signs licensing agreement with RFSUNY, gains patent rights to Transcobalamin Receptor

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News